1. Home
  2. PCB vs BNTC Comparison

PCB vs BNTC Comparison

Compare PCB & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCB Bancorp

PCB

PCB Bancorp

HOLD

Current Price

$28.09

Market Cap

410.1M

Sector

Finance

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$12.41

Market Cap

454.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCB
BNTC
Founded
2003
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
410.1M
454.2M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
PCB
BNTC
Price
$28.09
$12.41
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$25.50
$27.67
AVG Volume (30 Days)
41.1K
69.8K
Earning Date
04-23-2026
05-14-2026
Dividend Yield
3.65%
N/A
EPS Growth
48.28
80.94
EPS
0.74
N/A
Revenue
$2,899,000.00
N/A
Revenue This Year
$13.73
N/A
Revenue Next Year
$9.07
N/A
P/E Ratio
$38.01
N/A
Revenue Growth
4.51
N/A
52 Week Low
$19.70
$9.85
52 Week High
$30.84
$16.76

Technical Indicators

Market Signals
Indicator
PCB
BNTC
Relative Strength Index (RSI) 49.03 51.71
Support Level $27.31 $11.35
Resistance Level $29.29 $13.48
Average True Range (ATR) 0.94 0.70
MACD -0.22 0.01
Stochastic Oscillator 22.78 56.15

Price Performance

Historical Comparison
PCB
BNTC

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: